Literature DB >> 19681905

Cellular characterization of the peritumoral edema zone in malignant brain tumors.

Tobias Engelhorn1, Nic E Savaskan, Marc A Schwarz, Jürgen Kreutzer, Eric P Meyer, Eric Hahnen, Oliver Ganslandt, Arnd Dörfler, Christopher Nimsky, Michael Buchfelder, Ilker Y Eyüpoglu.   

Abstract

Brain edema is a hallmark of human malignant brain tumors and contributes to the clinical course and outcome of brain tumor patients. The so-called perifocal edema or brain swelling imposes in T2-weighted MR scans as high intensity areas surrounding the bulk tumor mass. The mechanisms of this increased fluid attraction and the cellular composition of the microenvironment are only partially understood. In this study, we focus on imaging perifocal edema in orthotopically implanted gliomas in rodents and correlate perifocal edema with immunohistochemical markers. We identified that areas of perifocal edema not only include the tumor invasion zone, but also are associated with increased glial fibrillary acidic protein (GFAP) and aquaporin-4 expression surrounding the bulk tumor mass. Moreover, a high number of activated microglial cells expressing CD11b and macrophage migration inhibitory factor (MIF) accumulate at the tumor border. Thus, the area of perifocal edema is mainly dominated by reactive changes of vital brain tissue. These data corroborate that perifocal edema identified in T2-weighted MR scans are characterized with alterations in glial cell distribution and marker expression forming an inflammatory tumor microenvironment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19681905     DOI: 10.1111/j.1349-7006.2009.01259.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  38 in total

1.  Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis.

Authors:  Andrés Server; Tone E Døli Orheim; Bjørn A Graff; Roger Josefsen; Theresa Kumar; Per H Nakstad
Journal:  Neuroradiology       Date:  2010-07-13       Impact factor: 2.804

2.  Expression of CXC-motif-chemokine 12 and the receptor C-X-C receptor 4 in glioma and theeffect on peritumoral brain edema.

Authors:  Wenlong Tang; Yupeng Chen; Xingfu Wang; Yao Chen; Jiandong Zhang; Zhixiong Lin
Journal:  Oncol Lett       Date:  2017-12-08       Impact factor: 2.967

3.  MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesis.

Authors:  A Ghoochani; M A Schwarz; E Yakubov; T Engelhorn; A Doerfler; M Buchfelder; R Bucala; N E Savaskan; I Y Eyüpoglu
Journal:  Oncogene       Date:  2016-05-09       Impact factor: 9.867

4.  Use of genetically engineered stem cells for glioma therapy.

Authors:  Hiroki Namba; Hiroshi Kawaji; Tomohiro Yamasaki
Journal:  Oncol Lett       Date:  2015-11-04       Impact factor: 2.967

5.  Radiomic features from the peritumoral brain parenchyma on treatment-naïve multi-parametric MR imaging predict long versus short-term survival in glioblastoma multiforme: Preliminary findings.

Authors:  Prateek Prasanna; Jay Patel; Sasan Partovi; Anant Madabhushi; Pallavi Tiwari
Journal:  Eur Radiol       Date:  2016-10-24       Impact factor: 5.315

6.  Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW.

Authors:  Jason M Warram; Esther de Boer; Melissa Korb; Yolanda Hartman; Joy Kovar; James M Markert; G Yancey Gillespie; Eben L Rosenthal
Journal:  Br J Neurosurg       Date:  2015-06-15       Impact factor: 1.596

7.  Measurements of diagnostic examination performance and correlation analysis using microvascular leakage, cerebral blood volume, and blood flow derived from 3T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in glial tumor grading.

Authors:  Andrés Server; Bjørn A Graff; Tone E Døli Orheim; Till Schellhorn; Roger Josefsen; Øystein B Gadmar; Per H Nakstad
Journal:  Neuroradiology       Date:  2010-09-21       Impact factor: 2.804

8.  Differentiation between brain glioblastoma multiforme and solitary metastasis: qualitative and quantitative analysis based on routine MR imaging.

Authors:  X Z Chen; X M Yin; L Ai; Q Chen; S W Li; J P Dai
Journal:  AJNR Am J Neuroradiol       Date:  2012-06-28       Impact factor: 3.825

9.  MRI assessment of experimental gliomas using 17.6 T.

Authors:  Marc A Schwarz; Mirko Pham; Xavier Helluy; Arnd Doerfler; Tobias Engelhorn
Journal:  Neuroradiology       Date:  2013-03-10       Impact factor: 2.804

Review 10.  Surgical resection of malignant gliomas-role in optimizing patient outcome.

Authors:  Ilker Y Eyüpoglu; Michael Buchfelder; Nic E Savaskan
Journal:  Nat Rev Neurol       Date:  2013-01-29       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.